-
An overview of neuro-ophthalmic disorders at Jenna Ophthalmic Center, Baghdad, Iraq (2021-2022)
-
Neuro-ophthalmic disorders are often documented individually for each illness, with little data available on their overall incidence and pattern. The overall incidence of neuro-ophthalmic illnesses in Iraq is still not recorded. This study aimed to evaluate the clinical, demographic, and etiological features of patients seeking consultation at an Iraqi neuro-ophthalmology clinic. A prospective cross-sectional observational research was conducted at the Janna Ophthalmic Center in Baghdad, Iraq. The center serves a diverse patient population from various governorates. All newly diagnosed patients with neuro-ophthalmic disorders who visited the neuro-ophthalmological clinic, regardless of gender or age group, were included. The neuro-ophthalmologist established a diagnosis for each case by reviewing the patient's medical history, doing physical examinations, administering specific tests, and, in certain cases, using neuroimaging methods. The duration of the study was extended from March 2021 to November 2022. Among the 6440 patients evaluated, 613 cases were confirmed at the neuro-ophthalmology clinic. Ischemic optic neuropathy (NAION, AION, and PION) was the most prevalent diagnosis, accounting for 17.61% of newly reported cases in the field of neuro-ophthalmology. This was followed by sixth nerve palsy. Diabetes mellitus affected 42.7% of the cases, followed by hypertension, which affected 39.3% of the participants. The incidence of neuro-ophthalmic diseases tended to be high. Ischemic optic neuropathy and sixth nerve palsy, traumatic/compressive optic neuropathy, and papilledema were the most common neuro-ophthalmic disorders reported.
-
PDF
-
NEBIVOLOL HYDROCHLORIDE LOADED NANOSTRUCTURED LIPID CARRIERS AS TRANSDERMAL DELIVERY SYSTEM:-PART 2:- HYDROGEL PREPARATION, EVALUATION AND PERMEATION STUDY
-
أ.م.د.اسراء غازي جبار2016
-
Nebivolol Hydrochloride Loaded Nanostructured Lipid Carriers as Transdermal Delivery System: Part 1: Preparation, Characterization and In Vitro Evaluation
-
أ.م.د.اسراء غازي جبار2016
-
Comparison of acute and delayed antiemetic effect of adding Aprepitant to Odansitron and Dexamethasone regimen in patients with Hodgkin lymphoma receiving highly emetogenic chemotherapy.
-
أ.م.د.اسراء غازي جبار2019
-
Etodolac Topical Spray Films, Development, Characterization and In-Vitro Evaluation
-
أ.م.د.اسراء غازي جبار2020
-
Nefopam induced dose-related changes in renal and hepatic functions
-
أ.م.د.اسراء غازي جبار2020
